Jay D. Pearson

10.1k citations

65 papers · 6.7k indexed · 2 hit papers · h-index 32

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Hormonal and reproductive studies
Sensory Systems top 0.5%
- Hearing, Cochlea, Tinnitus, Genetics

Papers in ⓘ

Pulmonary and Respiratory Medicine 25
- Prostate Cancer Diagnosis and Treatment 23
- Prostate Cancer Treatment and Research 19
Surgery 7

Co-authors: E. Jeffrey Metter (6 shared papers)Jordan D. Tobin (1 shared paper)S. Mitchell Harman (1 shared paper)Marc R. Blackman (1 shared paper)Larry J. Brant (16 shared papers)Alan W. Partin (12 shared papers)Patrick C. Walsh (10 shared papers)Christopher H. Morrell (12 shared papers)
Journals: Urology (10 papers)The Journal of Urology (9 papers)American Journal of Human Biology (5 papers)Urologic Clinics of North America (2 papers)European Journal of Cancer (2 papers)
Partner nations: United States United Kingdom South Korea

In The Last Decade

Jay D. Pearson

65 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium 2001 · 755 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Urology
2001 The Journal of Clinical Endocrinology & Metabolism

Peers

Countries citing papers authored by Jay D. Pearson

Since Specialization

Citations

This map shows the geographic impact of Jay D. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay D. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay D. Pearson more than expected).

Fields of papers citing papers by Jay D. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay D. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay D. Pearson. The network helps show where Jay D. Pearson may publish in the future.

Co-authors

The 25 scholars most cited alongside Jay D. Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay D. Pearson Line = papers co-authored together Jay D. Pearson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men The Journal of Clinical Endocrinology & Metabolism ·S. Mitchell Harman, E. Jeffrey Metter, Jordan D. Tobin, Jay D. Pearson, Marc R. Blackman Hit paper breakdown →	2001	2034
2	Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology ·Alan W. Partin, Leslie A. Mangold, Dana M Lamm, Patrick C. Walsh, Jonathan I. Epstein, Jay D. Pearson Hit paper breakdown →	2001	755
3	Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. PubMed ·Alan W. Partin, Michael W. Kattan, (unknown), Patrick Paul Walsh, (unknown), (unknown), Peter T. Scardino, Jay D. Pearson	1997	353
4	Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology ·Alan W. Partin, Charles R. Pound, Jay D. Pearson, J. Quentin Clemens, Patricia K. Landis, Jonathan I. Epstein, H.Ballentine Carter, Patrick C. Walsh	1994	328
5	Gender differences in a longitudinal study of age-associated hearing loss The Journal of the Acoustical Society of America ·Jay D. Pearson, Christopher H. Morrell, Sandra Gordon‐Salant, Larry J. Brant, E. Jeffrey Metter, Lisa L. Klein, James L. Fozard	1995	307
6	The GRID-HAMD: standardization of the Hamilton Depression Rating Scale International Clinical Psychopharmacology ·Janet B. W. Williams, Kenneth A. Kobak, Per Bech, Nina Engelhardt, Kenneth Evans, Joshua D. Lipsitz, Jason T. Olin, Jay D. Pearson, Amir H Kalali	2008	231
7	Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. PubMed ·H B Carter, Christopher H. Morrell, Jay D. Pearson, Larry J. Brant, Chris C. Plato, E. Jeffrey Metter, Danny Chan, James L. Fozard, Patrick C. Walsh	1992	167
8	Age- and gender-specific reference ranges for hearing level and longitudinal changes in hearing level The Journal of the Acoustical Society of America ·Christopher H. Morrell, Sandra Gordon‐Salant, Jay D. Pearson, Larry J. Brant, James L. Fozard	1996	152
9	Risk factors related to age-associated hearing loss in the speech frequencies. PubMed ·Larry J. Brant, Sandra Gordon‐Salant, Jay D. Pearson, Lisa L. Klein, Christopher H. Morrell, E. Jeffrey Metter, James L. Fozard	1996	149
10	VALIDATION OF PARTIN TABLES FOR PREDICTING PATHOLOGICAL STAGE OF CLINICALLY LOCALIZED PROSTATE CANCER The Journal of Urology ·Michael L. Blute, Erik J. Bergstralh, Alan W. Partin, Patrick C. Walsh, Michael W. Kattan, Peter T. Scardino, James E. Montie, Jay D. Pearson, Jeffrey M. Slezak, Horst Zincke	2000	129
11	A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial Prostatitis The Journal of Urology ·J. Curtis Nickel, Michel A. Pontari, Timothy Moon, Marc Gittelman, G.H. Malek, Jean W. Farrington, Jay D. Pearson, David Krupa, Mark A. Bach, Jennifer E. Drisko, (unknown)	2003	118
12	Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity Urology ·H. Ballentine Carter, Daniel W. Chan, Jay D. Pearson, Harry A. Guess, Zenon Waclawiw, Patrick C. Walsh, E. Jeffrey Metter	1995	116
13	Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index?Emesis (FLIE) with 5-day recall Supportive Care in Cancer ·Beilei Cai, M. Elmer, Celeste Lindley, Jay D. Pearson, Allison Martin, Kevin Horgan	2003	113
14	Longitudinal evaluation of serum androgen levels in men with and without prostate cancer The Prostate ·H. Ballentine Carter, Jay D. Pearson, E. Jeffrey Metter, Daniel W. Chan, Reubin Andres, James L. Fozard, William Rosner, Patrick C. Walsh	1995	107
15	Age-Associated Changes in Blood Pressure in a Longitudinal Study of Healthy Men and Women The Journals of Gerontology Series A ·Jay D. Pearson, Christopher H. Morrell, Larry J. Brant, P. Landis, Jerome L. Fleg	1997	106
16	Linear Transformations of Linear Mixed-Effects Models The American Statistician ·Christopher H. Morrell, Jay D. Pearson, Larry J. Brant	1997	105
17	Basal DNA damage in individual human lymphocytes with age Mutation Research/DNAging ·Narendra P. Singh, David B. Danner, Raymond R. Tice, Jay D. Pearson, Larry J. Brant, Chris Morrell, Edward L. Schneider	1991	104
18	Epidemiologic study on survival of chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia patients with BCR-ABL T315I mutation Blood ·Franck E. Nicolini, Michael J. Mauro, Giovanni Martinelli, Dong‐Wook Kim, Simona Soverini, Martin C. Müller, Andreas Hochhaus, Jörge E. Cortes, Charles Chuah, Inge Høgh Dufva, Jane F. Apperley, Fumiharu Yagasaki, Jay D. Pearson, Senaka Peter, Cesar Sanz Rodriguez, Claude Preudhomme, Francis J. Giles, John M. Goldman, Wei Zhou	2009	100
19	Longitudinal Changes in Smell Identification The Journals of Gerontology Series A ·Jonathan A. Ship, Jay D. Pearson, L. J. Cruise, Larry J. Brant, E. Jeffrey Metter	1996	83
20	Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis Urology ·H. Ballentine Carter, A. Partin, Albert A. Luderer, E. Jeffrey Metter, Patricia Landis, Daniel W. Chan, James L. Fozard, Jay D. Pearson	1997	74

About Jay D. Pearson

Jay D. Pearson is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Rheumatology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 65 papers that have together received 6.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (19 papers), Hormonal and reproductive studies (6 papers), Urologic and reproductive health conditions (6 papers), Urinary Bladder and Prostate Research (5 papers), Health disparities and outcomes (5 papers), Noise Effects and Management (4 papers) and Statistical Methods in Clinical Trials (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Sensory Systems (462 citations), Pulmonary and Respiratory Medicine (2.6k citations), Urology (425 citations) and Reproductive Medicine (466 citations). Jay D. Pearson has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include E. Jeffrey Metter, Jordan D. Tobin, S. Mitchell Harman, Marc R. Blackman, Larry J. Brant, Alan W. Partin, Patrick C. Walsh, Christopher H. Morrell, Jonathan I. Epstein and James L. Fozard. Their work appears in journals such as Urology, The Journal of Urology, American Journal of Human Biology, Urologic Clinics of North America and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact